Cargando…

Clinical trials of self-replicating RNA-based cancer vaccines

Therapeutic cancer vaccines, designed to activate immune effectors against tumor antigens, utilize a number of different platforms for antigen delivery. Among these are messenger RNAs (mRNA), successfully deployed in some prophylactic SARS-CoV2 vaccines. To enhance the immunogenicity of mRNA-deliver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morse, Michael A., Crosby, Erika J., Force, Jeremy, Osada, Takuya, Hobeika, Amy C., Hartman, Zachary C., Berglund, Peter, Smith, Jonathan, Lyerly, H. Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911953/ https://www.ncbi.nlm.nih.gov/pubmed/36765179 http://dx.doi.org/10.1038/s41417-023-00587-1

Ejemplares similares

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
por: Crosby, Erika J, et al.
Publicado: (2020)

Cancer vaccine strategies using self-replicating RNA viral platforms
por: Dailey, Gabrielle P., et al.
Publicado: (2022)

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets
por: Crosby, Erika J., et al.
Publicado: (2023)

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
por: Crosby, Erika J., et al.
Publicado: (2021)

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
por: Osada, Takuya, et al.
Publicado: (2018)

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
por: Morse, Michael A, et al.
Publicado: (2015)

Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
por: Kaneko, Kensuke, et al.
Publicado: (2022)

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2
por: Morse, Michael A, et al.
Publicado: (2007)

Self-replicating messenger RNA based cancer immunotherapy
por: Lyerly, Herbert Kim
Publicado: (2023)

HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
por: Osada, Takuya, et al.
Publicado: (2022)

Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
por: Ren, Xiu-Rong, et al.
Publicado: (2012)

Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
por: Hamilton, Erika, et al.
Publicado: (2013)

Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity
por: Osada, Takuya, et al.
Publicado: (2009)

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
por: Osada, T, et al.
Publicado: (2010)

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
por: Hamilton, Erika, et al.
Publicado: (2012)

Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771
por: Gray, Michael, et al.
Publicado: (2015)

A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity
por: Kaneko, Kensuke, et al.
Publicado: (2022)

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
por: Morse, Michael A, et al.
Publicado: (2005)

Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer
por: Huang, Lefu, et al.
Publicado: (2019)

Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
por: Hwang, Bin-Jin, et al.
Publicado: (2022)

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors
por: Crosby, Erika J., et al.
Publicado: (2018)

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
por: Abe, Shinya, et al.
Publicado: (2022)

Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth
por: Ren, Xiu-Rong, et al.
Publicado: (2015)

Next generation self-replicating RNA vectors for vaccines and immunotherapies
por: Aliahmad, Parinaz, et al.
Publicado: (2022)

Self-Replicating RNA
por: Tews, Birke Andrea, et al.
Publicado: (2016)

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity
por: Amano, Tomokazu, et al.
Publicado: (2023)

Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer
por: Lundstrom, Kenneth
Publicado: (2021)

Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
por: Kim, Byungji, et al.
Publicado: (2023)

Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants
por: Uronis, Joshua M., et al.
Publicado: (2012)

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
por: Yang, Duo, et al.
Publicado: (2021)

Self-Replicating RNA Viruses for RNA Therapeutics
por: Lundstrom, Kenneth
Publicado: (2018)

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis
por: Tsao, Li-Chung, et al.
Publicado: (2022)

The prognostic value of peripheral CD4(+)CD25(+) T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion
por: Song, Qing-Kun, et al.
Publicado: (2015)

Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
por: Zhong, Zifu, et al.
Publicado: (2019)

A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
por: de Alwis, Ruklanthi, et al.
Publicado: (2021)

Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses
por: Lundstrom, Kenneth
Publicado: (2022)

HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression
por: Chen, Alan Chen, et al.
Publicado: (2020)

Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors
por: Crosby, Catherine M., et al.
Publicado: (2017)

Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials
por: Jaffe, Elana, et al.
Publicado: (2020)

Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2
por: Lin, Guibin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19uqhg1si404kkf8trg9mgec7u